← Back to headlines
Mars CEO Joins Board of GLP-1 Drug Supplier Novo Nordisk
The CEO of Mars has been appointed to a board role at Novo Nordisk, a major supplier of GLP-1 drugs, signaling a significant corporate development for the pharmaceutical company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in Intensive Care After Concert Illness
1h ago
Lionel Richie Hospitalized in ICU Following St. Louis Concert
2h ago
Novartis Pauses Autoimmune Cell Therapy Trials Following Patient Deaths
4h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
14h ago